Division of Endocrinology and Diabetes at the Children's Hospital of Philadelphia, 11NW Tower, 34th and Civic Center Boulevard, Philadelphia, Pennsylvania 19104, USA.
J Clin Endocrinol Metab. 2012 Nov;97(11):E2152-9. doi: 10.1210/jc.2012-1988. Epub 2012 Aug 14.
Adipose inflammation is a crucial link between obesity and its metabolic complications. Human experimental endotoxemia is a controlled model for the study of inflammatory cardiometabolic responses in vivo.
We hypothesized that adipose genes down-regulated during endotoxemia would approximate changes observed with obesity-related inflammation and reveal novel candidates in cardiometabolic disease.
DESIGN, SUBJECTS, AND INTERVENTION: Healthy volunteers (n = 14) underwent a 3 ng/kg endotoxin challenge; adipose biopsies were taken at 0, 4, 12, and 24 h for mRNA microarray. A priority list of highly down-regulated and biologically relevant genes was validated by RT-PCR in an independent sample of adipose from healthy subjects (n = 7) undergoing a subclinical 0.6 ng/kg endotoxemia protocol. Expression of validated genes was screened in adipose of lean and severely obese individuals (n = 11 per group), and cellular source was probed in cultured adipocytes and macrophages.
Endotoxemia (3 ng/kg) suppressed expression of 353 genes (to <67% of baseline; P < 1 × 10(-5)) of which 68 candidates were prioritized for validation. In low-dose (0.6 ng/kg) endotoxin validation, 22 (32%) of these 68 genes were confirmed. Functional classification revealed that many of these genes are involved in cell development and differentiation. Of validated genes, 59% (13 of 22) were down-regulated more than 1.5-fold in primary human adipocytes after treatment with endotoxin. In human macrophages, 59% (13 of 22) were up-regulated during differentiation to inflammatory M1 macrophages whereas 64% (14 of 22) were down-regulated during transition to homeostatic M2 macrophages. Finally, in obese vs. lean adipose, 91% (20 of 22) tended to have reduced expression (χ(2) = 10.72, P < 0.01) with 50% (11 of 22) reaching P < 0.05 (χ(2) = 9.28, P < 0.01).
Exploration of down-regulated mRNA in adipose during human endotoxemia revealed suppression of genes involved in cell development and differentiation. A majority of candidates were also suppressed in endogenous human obesity, suggesting a potential pathophysiological role in human obesity-related adipose inflammation.
脂肪炎症是肥胖及其代谢并发症之间的关键环节。人体实验性内毒素血症是研究体内炎症性心血管代谢反应的一种受控模型。
我们假设在内毒素血症期间下调的脂肪基因与肥胖相关炎症相似,并揭示心血管代谢疾病的新候选基因。
设计、对象和干预:健康志愿者(n = 14)接受 3ng/kg 内毒素挑战;在 0、4、12 和 24 小时取脂肪活检,用于 mRNA 微阵列。通过 RT-PCR 在接受亚临床 0.6ng/kg 内毒素方案的健康受试者的独立脂肪样本中验证高度下调和生物学相关基因的优先级列表(n = 7)。在瘦人和严重肥胖个体的脂肪中筛选验证基因的表达(每组 n = 11),并在培养的脂肪细胞和巨噬细胞中探测细胞来源。
内毒素(3ng/kg)抑制了 353 个基因的表达(<67%的基线;P < 1×10(-5)),其中 68 个候选基因被优先验证。在低剂量(0.6ng/kg)内毒素验证中,这些 68 个基因中有 22 个(32%)得到确认。功能分类显示,这些基因中有许多涉及细胞发育和分化。在验证的基因中,59%(13 个中的 22 个)在用内毒素处理后在原代人脂肪细胞中下调超过 1.5 倍。在人巨噬细胞中,59%(22 个中的 13 个)在分化为炎症性 M1 巨噬细胞时上调,而 64%(22 个中的 14 个)在向稳态 M2 巨噬细胞转化时下调。最后,在肥胖与瘦的脂肪中,91%(22 个中的 20 个)倾向于表达降低(χ(2) = 10.72,P < 0.01),其中 50%(22 个中的 11 个)达到 P < 0.05(χ(2) = 9.28,P < 0.01)。
在人体内毒素血症期间探索脂肪中下调的 mRNA 揭示了抑制参与细胞发育和分化的基因。大多数候选基因在人类内源性肥胖中也受到抑制,这表明它们在人类肥胖相关脂肪炎症中具有潜在的病理生理作用。